WEDNESDAY, July 4 (HealthDay News) -- Routine screening of the embryos of older mothers won't increase their chances of successful pregnancy after in vitro fertilization, and might even have the opposite effect, a new Dutch study suggests.
In the July 5 issue of the New England Journal of Medicine, European researchers report that the live birth rate for older women who had preimplantation screening as part of the in vitro fertilization (IVF) procedure was 24 percent compared to 35 percent in women who had IVF without preimplantation screening.
"Preimplantation genetic screening is meant to increase the chance to achieve a live birth," said Sjoerd Repping, director of the IVF laboratory at the Center for Reproductive Medicine at the Academic Medical Center in Amsterdam. Instead, Repping said, "PGS significantly reduces the chance of an ongoing pregnancy in women of advanced maternal age."
Preimplantation genetic screening is done by removing one or two cells from an embryo before it's implanted in the mother's uterus. Those cells are then tested for certain known abnormalities, such as cystic fibrosis, Huntington's disease and sickle cell anemia. The procedure adds between $3,000 and $5,000 to an IVF attempt, but for people at high risk of transmitting a genetic abnormality, it can help assure a healthy pregnancy.
"Preimplantation genetic diagnosis is not without risk, however," wrote Dr. John Collins from McMaster University in an accompanying editorial. On average, live birth rates are lower after preimplantation screening, according to Collins.
Dr. Jamie Grifo, director of the division of reproductive endocrinology at the New York University School of Medicine, said he believed the act of taking a biopsy from the embryo to remove the cells for genetic testing does reduce the pregnancy rate "to some extent."
But, he added, in certain high-risk women, the benefits of knowing that you're not transmitting a devastating genetic illness to your offspring outweigh the risks of the procedure.
The current study included 408 women between 35 and 41 years old, ages that are considered "advanced" when trying to conceive. Two hundred and six were randomly assigned to the preimplantation genetic screening group and the remainder to a control group receiving standard IVF.
The rates of ongoing pregnancy -- defined as a pregnancy lasting 12 weeks or longer -- was 25 percent in the preimplantation screening group versus 37 percent in the non-screening group. And, live birth rates were 24 percent and 35 percent, respectively.
Repping said that several factors may be responsible for this difference. The first is that the act of taking a biopsy may damage embryos somehow. Another is due to technical limitations of the preimplantation screening -- embryos currently thought to be normal may actually have unknown defects. And, finally, the cell or cells tested may not be representative of the whole embryo.
"Preimplantation genetic screening is an expensive technique that is very frequently offered to women of advanced maternal age under the statement that it will increase pregnancy rates. The fact that the data show that it does not -- on the contrary, it decreases pregnancy rates -- should be included in the counseling of these patients undergoing IVF treatment," said Repping.